Latest Advancements in Biopharmaceutical Research and Technologies
Discover a range of new technologies and applications for biopharmaceutical development in this special editorial feature
Discover a range of new technologies and applications for biopharmaceutical development in this special editorial feature
This new range of kits is said to deliver high-quality ChIP-ready chromatin from as little as 5 Drosophila specimens
Novel cyclic IMS and new SYNAPT XS lead Waters’ portfolio of solutions that promise unlimited experimental opportunities and analytical flexibility
As the global antibody market hits new heights, meet one scientist working to bridge the gap between biomarker discovery and antibody development with high-speed phage-display technology
Collaborative project has successfully demonstrated that aging in nematodes is partially programmed and can be modified therapeutically
Real-time, live-cell imaging and analysis tools for effective antibody characterization
The new collaborative project aims to explore the potential use of aptamers as treatment for myeloid malignancies
This new solution could enable large-scale AAV vector production for gene therapy
A study from the University of Cambridge highlights potential new treatment for neurodegeneration
Single cell-sequencing technology will be used by Labcorp to support clinical trials and evaluate potential applications in clinical diagnostics and companion diagnostics development
The Unyvero Platform allows rapid testing for a broad range of pathogens and antibiotic resistance markers associated with life-threatening infections in hospitalized patients
Visit booth 1413 at the SLAS2019 conference in Washington D.C., USA, to pick up a limited edition T-shirt in exchange for a 2-minute lab product review – there are four fab designs to choose from
As the number of analytical monitoring tests for biopharmaceuticals skyrockets, Waters builds intelligence into a fit-for-purpose system
We asked you how science would change the world in the next 20 years – here's what you said
SelectScience reflects on the biggest and best drug discovery stories of the year
GARDP, Eisai and Takeda announce partnership in the search for new antibiotics
Multi-centre study published in New England Journal of Medicine suggests CAR-T therapy could improve outcome in B-cell lymphoma patients
The facility for producing fiber-based chromatography platforms for more efficient biopharmaceutical purification will become operational in 2019
Christoph Roesli, scientist and reviewer of the month, describes his fascinating journey through science, and gives his top tips on selecting equipment when establishing a new research group
Molecular Devices announces brand identity for its newly-formed biologics business unit
First of its kind plug-and-play benchtop bioreactor by Distek, Inc., awarded patent
Join SelectScience and Dr. Richard Eglan for a specialist drug discovery webinar on 3D cell culture technology